Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordicus Partners
Beverly Hills, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Nordicus Partners supports Nordic life sciences companies entering the U.S. market; its portfolio includes Orocidin (developing treatments for aggressive periodontal disease) and Bio-Convert (focused on preventing oral leukoplakia). No direct clinical results for Nordicus; results would be at subsidiary/portfolio level.
- Therapeutic areas
- OncologyOther
- Modalities
- Small moleculeBiologic
- Industry
- Investors
02
Partnerships
Strategic alliances with Nordic and U.S. life sciences companies (details not specified)
Beyond the preview
Go deeper on Nordicus Partners.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nordicus Partners.